Bayer to Renew 3.5 Billion-Euro Credit Line Early
This article is for subscribers only.
Bayer AG, Europe’s largest drug and chemical maker, plans to renew a 3.5 billion-euro ($4.7 billion) credit line in the first quarter, a year ahead of schedule, to benefit from banks’ appetite for high-grade company loans.
“We want to take advantage of the favorable market situation,” Guenter Forneck, a spokesman for Leverkusen, Germany-based Bayer, said today by phone. “We have no plan to use the credit line.”